Accuray Incorporated (ARAY)

Market Cap	126.71M
Revenue (ttm)	465.25M
Net Income (ttm)	673,000
Shares Out	103.01M
EPS (ttm)	0.01
PE Ratio	184.57
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	493,888
Open	1.220
Previous Close	1.220
Day's Range	1.210 - 1.230
52-Week Range	1.140 - 2.950
Beta	1.31
Analysts	n/a
Price Target	n/a
Earnings Date	Apr 30, 2025

About ARAY

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, a...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Feb 8, 2007
• Employees: 987
• Stock Exchange: NASDAQ
• Ticker Symbol: ARAY
• Website: https://www.accuray.com

Financial Performance

In 2024, Accuray's revenue was $446.55 million, a decrease of -0.24% compared to the previous year's $447.61 million. Losses were -$15.55 million, 67.5% more than in 2023.